secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVENUE THERAPEUTICS, INC. (ATXI)
CIK:        0001644963
Form:       8-K
Filed at:   2024-05-01T23:59:59+00:00
Accession:  0001437749-24-014178
Event type: debt
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 3.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avenue Therapeutics raises $4.4M via warrant exercise inducement; issues new warrants
--------------------------------------------------------------------------------

- Holders exercised 689,680 existing warrants at reduced price of $6.20/share for $4.4M gross proceeds.
- In exchange, Company issued new Series C and Series D warrants to purchase up to 689,680 shares each at $6.20.
- Series C warrants exercisable for 5 years; Series D for 18 months; Placement agent got warrants at $7.75.
- Proceeds used for general corporate purposes; H.C. Wainwright acted as exclusive placement agent.
- Existing warrants (Oct 2022, Nov 2023, Jan 2024) had exercise prices of $116.25, $22.545, and $22.545.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1644963/000143774924014178/0001437749-24-014178-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1644963/000143774924014178/atxi20240501_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-014178

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer